KARINA GAYOSSO: Open Payments
NPI 1437810660 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 34 payments from 8 companies in 2025. Trend: 2023 $512 · 2024 $712 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $316 |
| Lilly USA, LLC | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 1 | $70 |
| Novo Nordisk Inc | 3 | $61 |
| Amgen Inc. | 3 | $44 |
| PFIZER INC. | 2 | $38 |
| Exact Sciences Corporation | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: AIRSUPRA, MOUNJARO, FARXIGA, REXULTI, Wegovy, BREZTRI, PAXLOVID, REPATHA.
Industry payments across NM — which companies pay providers there.
